Public Profile

Vitex Pharmaceuticals

Vitex Pharmaceuticals, also known as Vitex Pharma, is a prominent player in the pharmaceutical industry, headquartered in Australia. Founded in 2001, the company has established itself as a leader in the development and manufacturing of high-quality, innovative healthcare products. With a strong operational presence across Australia and key markets in Asia, Vitex Pharmaceuticals focuses on prescription medications, over-the-counter products, and nutraceuticals. The company is renowned for its commitment to quality and efficacy, offering unique formulations that cater to diverse health needs. Notable achievements include several industry awards recognising their contributions to healthcare and a robust portfolio of products that address various therapeutic areas. Vitex Pharmaceuticals continues to strengthen its market position through ongoing research and development, ensuring it remains at the forefront of the pharmaceutical landscape.

DitchCarbon Score

How does Vitex Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

8

Industry Benchmark

Vitex Pharmaceuticals's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Vitex Pharmaceuticals's reported carbon emissions

Vitex Pharmaceuticals, headquartered in Australia, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of documented reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Vitex to establish clear emissions reduction goals and engage in climate action to align with global standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vitex Pharmaceuticals's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Vitex Pharmaceuticals is headquartered in AU, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vitex Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Research Services

Gulf Research Center

SA
Research Services
Updated 10 days ago

GHA TECHNOLOGIES INC

US
Research Services
Updated 11 days ago

Stoneygate Eye Hospital

GB
Research Services
Updated 11 days ago

MOSCOW CUSTOMS

ES
Research Services
Updated 11 days ago

Ascentys

FR
Research Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers